雅培凭借心脏医疗设备业务的强劲表现上调2026年盈利预期

路透中文
Jul 16
<a href="https://laohu8.com/S/ABT">雅培</a>凭借心脏医疗设备业务的强劲表现上调2026年盈利预期

路透7月16日 - 雅培 ABT.N 周四上调了年度利润预期,因其预计下半年心脏设备需求将保持强劲。

该公司预计2026年经调整后每股收益将在5.45至5.60美元之间,而此前预测为每股5.38至5.58美元。

根据伦敦证券交易所集团(LSEG)汇编的数据,分析师此前平均预期其年度每股收益为5.49美元。

受心脏和糖尿病设备需求稳定支撑,近几个季度投资者对医疗器械制造商的信心有所提升。

该公司仍预计全年销售额增长将在6.5%至7.5%之间。

这家医疗器械制造商报告称,季度经调整后每股收益为1.31美元,高于分析师预期的1.28美元。

第二季度总营收为126亿美元,高于市场预期的125亿美元。

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10